These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19439228)

  • 1. Differential genomic and proteomic profiling of glioblastoma cells exposed to terpyridineplatinum(II) complexes.
    Koncarevic S; Urig S; Steiner K; Rahlfs S; Herold-Mende C; Sueltmann H; Becker K
    Free Radic Biol Med; 2009 Apr; 46(8):1096-108. PubMed ID: 19439228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HDAC inhibitor depsipeptide transactivates the p53/p21 pathway by inducing DNA damage.
    Wang H; Zhou W; Zheng Z; Zhang P; Tu B; He Q; Zhu WG
    DNA Repair (Amst); 2012 Feb; 11(2):146-56. PubMed ID: 22112863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells.
    Gan L; Yang XL; Liu Q; Xu HB
    J Cell Biochem; 2005 Oct; 96(3):653-64. PubMed ID: 16088946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles.
    Cassidy PB; Edes K; Nelson CC; Parsawar K; Fitzpatrick FA; Moos PJ
    Carcinogenesis; 2006 Dec; 27(12):2538-49. PubMed ID: 16777982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
    Wang X; Zhang J; Xu T
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
    Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
    Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiglioma activity of 2,2':6',2"-terpyridineplatinum(II) complexes in a rat model--effects on cellular redox metabolism.
    Ahmadi R; Urig S; Hartmann M; Helmke BM; Koncarevic S; Allenberger B; Kienhoefer C; Neher M; Steiner HH; Unterberg A; Herold-Mende C; Becker K
    Free Radic Biol Med; 2006 Mar; 40(5):763-78. PubMed ID: 16520229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
    Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
    Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
    Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
    Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis identifies protein targets responsible for depsipeptide sensitivity in tumor cells.
    Chen G; Li A; Zhao M; Gao Y; Zhou T; Xu Y; Du Z; Zhang X; Yu X
    J Proteome Res; 2008 Jul; 7(7):2733-42. PubMed ID: 18549279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity.
    Seemann S; Hainaut P
    Oncogene; 2005 Jun; 24(24):3853-63. PubMed ID: 15824742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the potential of thioredoxin reductase inhibitors for cancer therapy.
    Urig S; Becker K
    Semin Cancer Biol; 2006 Dec; 16(6):452-65. PubMed ID: 17056271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
    Tonissen KF; Di Trapani G
    Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
    Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
    Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p53/p21/PUMA alliance and disruption of PI-3/Akt in multimodal targeting of apoptotic signaling cascades in cervical cancer cells by a pentacyclic triterpenediol from Boswellia serrata.
    Bhushan S; Malik F; Kumar A; Isher HK; Kaur IP; Taneja SC; Singh J
    Mol Carcinog; 2009 Dec; 48(12):1093-108. PubMed ID: 19544329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thioredoxin reductase--a new target for molecular medical investigations].
    Zagrodzki P
    Postepy Hig Med Dosw; 2002; 56(2):155-67. PubMed ID: 12107960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase.
    Bellisola G; Fracasso G; Ippoliti R; Menestrina G; Rosén A; Soldà S; Udali S; Tomazzolli R; Tridente G; Colombatti M
    Biochem Pharmacol; 2004 May; 67(9):1721-31. PubMed ID: 15081871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest.
    Lu X; Qian J; Yu Y; Yang H; Li J
    Oncol Rep; 2009 Sep; 22(3):635-40. PubMed ID: 19639215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
    Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
    Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.